Home Drug Codes J Codes J9263 · OXALIPLATIN
Updated July 1st, 2026

OXALIPLATIN J Code: J9263

Injection, oxaliplatin, 0.5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9263, effective October 1, 2026: $0.087 per HCPCS billing unit, up 58.2% from $0.055. From CMS's final file.

?
Medicare Payment Limit ?
$0.055
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
51
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, oxaliplatin, 0.5 mg
HCPCS Added Date January 1, 2004
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Solution | Injection, Solution, Concentrate | Not Available

About OXALIPLATIN

Oxaliplatin is a medication aligned to the HCPCS J Code: J9263 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat advanced cancer of the colon and rectum. Oxaliplatin is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 51 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00703-3985-01 Oxaliplatin Teva Parenteral Medicines, Inc. 100 50 MG / 10 ML
00781-3315-70 Oxaliplatin Sandoz Inc 100 50 MG / 10 ML
00955-1727-20 Oxaliplatin Sanofi-Aventis U.S. LLC 200 100 MG / 20 ML
16729-0332-03 oxaliplatin Accord Healthcare Inc. 100 50 MG / 10 ML
25021-0233-10 oxaliplatin Sagent Pharmaceuticals 100 50 MG / 10 ML
•••••-••••-•• Log in to view OXALIPLATIN
OXALIPLATIN
OXALIPLATIN
Login to view 46 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

OXALIPLATIN Pricing & Reimbursement

J9263 Private Payer Reimbursement
$0.06 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

OXALIPLATIN Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 10.92%
Avg. Days to File 10.4days
Avg. Days to Pay 24.9days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9263 claims analytics on FocalPoint →
OnPoint Oncology

OXALIPLATIN CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Oxaliplatin (J9263) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

OXALIPLATIN Medically Unlikely Edits (MUE)

The most billing units of J9263 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.5 mg.

Practitioner Office & Hospital Outpatient
700 units / day
= 350 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

OXALIPLATIN Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Advanced colorectal cancer Stage III colon cancer
Drug Class
Platinum-based Drug [EPC]Platinum-containing Compounds [EXT]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Oxaliplatin billing and coding guide?
We have not yet identified a manufacturer source of Oxaliplatin billing and coding information.
Are there any available Oxaliplatin patient assistance programs?
Our team did not identify a source for Oxaliplatin patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Oxaliplatin prescribing information?
OXALIPLATIN prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Oxaliplatin side effect information?
Our team has not yet identified a source of side effects information for OXALIPLATIN. Please check back in a few weeks.
Does billing OXALIPLATIN require JZ/JW wastage modifiers?
CMS has identified OXALIPLATIN(J9263) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.